Faculty of Medicine and Health Sciences, Oral Health Sciences, Department of Periodontology and Oral Implantology, Ghent University, Ghent, Belgium.
Faculty of Medicine and Pharmacy, Oral Health Research Group (ORHE), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
J Clin Periodontol. 2021 May;48(5):618-626. doi: 10.1111/jcpe.13453. Epub 2021 Mar 30.
(1) To assess prescription of systemic antibiotics following initial periodontal therapy with and without the availability of microbiological information; (2) To identify factors associated with prescription of systemic antibiotics following initial periodontal therapy.
Twenty-four clinicians were invited to complete a questionnaire on 20 patient records with respect to periodontal treatment planning, once with microbiological information available and once without. Randomization determined when the microbiological information was provided, and a 3-month washout period was respected between scoring sessions. Regression analysis was performed to identify factors associated with prescription of systemic antibiotics.
Twenty-one clinicians completed both scoring sessions. Clinicians prescribed systemic antibiotics in on average 56% (95% Confidence Interval (CI) [0.51; 0.61]) of the cases having microbiological information, and in 52% (95% CI [0.47; 0.57]) of the same cases not having that information (p = 0.094). The odds for prescribing systemic antibiotics were 3.34 (95% CI [2.06; 5.42]) times higher when the clinician had at least 3 years of experience, 2.55 (95% CI [1.40; 4.66]) times higher for patients diagnosed with periodontitis stage IV when compared to stage III, 1.08 (95% CI [1.04; 1.11]) times higher for younger patients, 2.78 times (95% CI [1.37; 5.56]) times higher for non-smokers and 2.22 (95% CI [1.27; 3.85]) times higher when less than three teeth would require extraction. No significant associations with the prescription of systemic antibiotics were found for detection of A.actinomycetemcomitans (p = 0.287), grade of periodontitis (p = 0.499) and gender of the patient (p = 0.067).
Based on a limited number of cases and clinicians, several patient and clinician related factors were associated with prescription of systemic antibiotics following initial periodontal therapy. However, microbiological testing was not.
(1)评估初始牙周治疗后是否有微生物信息指导下开具全身抗生素的处方;(2)确定与初始牙周治疗后开具全身抗生素相关的因素。
24 名临床医生受邀完成 20 份病历的问卷调查,一次有微生物信息,一次没有。随机确定何时提供微生物信息,两次评分之间有 3 个月的洗脱期。进行回归分析以确定与开具全身抗生素相关的因素。
21 名临床医生完成了两次评分。在有微生物信息的情况下,临床医生平均开具全身抗生素处方的比例为 56%(95%置信区间(CI)[0.51;0.61]),在没有该信息的情况下为 52%(95%CI [0.47;0.57])(p=0.094)。当临床医生有至少 3 年经验时,开具全身抗生素的可能性是 3.34 倍(95%CI [2.06;5.42]),与 III 期相比,诊断为牙周炎 IV 期的患者高 2.55 倍(95%CI [1.40;4.66]),年轻患者高 1.08 倍(95%CI [1.04;1.11]),不吸烟者高 2.78 倍(95%CI [1.37;5.56]),需要拔牙的牙齿少于 3 颗的患者高 2.22 倍(95%CI [1.27;3.85])。未发现全身抗生素处方与 A.actinomycetemcomitans 的检测(p=0.287)、牙周炎的严重程度(p=0.499)和患者性别(p=0.067)显著相关。
根据有限数量的病例和临床医生,一些与患者和临床医生相关的因素与初始牙周治疗后开具全身抗生素的处方相关,但微生物检测无相关性。